<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Experimental and clinical studies give evidence for breakdown of membrane <z:chebi fb="1" ids="16247">phospholipids</z:chebi> during <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we measured the levels of <z:chebi fb="0" ids="36313">glycerophosphocholine</z:chebi> (GPCh), <z:chebi fb="0" ids="36700">phosphocholine</z:chebi> (PCh), and <z:chebi fb="3" ids="15354">choline</z:chebi>, that is, water-soluble metabolites of <z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi> (PtdCho), in human cerebrospinal fluid (CSF) </plain></SENT>
<SENT sid="2" pm="."><plain>Among 30 cognitively <z:mpath ids='MPATH_458'>normal</z:mpath> patients the average CSF levels of GPCh, <z:chebi fb="0" ids="36700">phosphocholine</z:chebi> and <z:chebi fb="3" ids="15354">choline</z:chebi> were 3.64, 1.28, and 1.93 microM, respectively; metabolite levels did not change with increasing age </plain></SENT>
<SENT sid="3" pm="."><plain>When compared with age-matched controls, patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> had elevated levels of <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="3" ids="15354">choline</z:chebi> metabolites: GPCh was significantly increased by 76% (P&lt;0.01), <z:chebi fb="0" ids="36700">phosphocholine</z:chebi> by 52% (P&lt;0.05), and free <z:chebi fb="3" ids="15354">choline</z:chebi> (Ch) by 39% </plain></SENT>
<SENT sid="4" pm="."><plain>Six patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> had lower <z:chebi fb="3" ids="15354">choline</z:chebi> and elevated <z:chebi fb="0" ids="36700">phosphocholine</z:chebi> levels, when compared to controls, but <z:mpath ids='MPATH_458'>normal</z:mpath> levels of GPCh </plain></SENT>
<SENT sid="5" pm="."><plain>These data demonstrate that <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> is accompanied by an increased PtdCho hydrolysis in the brain </plain></SENT>
<SENT sid="6" pm="."><plain>PtdCho breakdown seems to be mediated by phospholipase A2 and leads to significantly elevated levels of GPCh in CSF </plain></SENT>
</text></document>